Imho we do not have to have human data from DX-1 trials to get other partners involved with DX-3, but what we do need is money to reactivate DX-3 research, as soon as the GMP for DX-1 is announced as being successful then i'd expect to be multiples of where we are now and then CR and then DX-3 will recommence.....THIS IS WHERE THE APRTNERIING WILL COPME FROM AND FROM A FEW DIFFERING PARTNERS AT THAT..
From the 4c
""The availability of a GLP manufacturing process for PAT-DX3 is expected to facilitate ongoing partnering discussions for this deoxymab and the Company intends to initiate its own production run of PAT-DX3 once it has access to additional capital.""
The end of this year could bring in so much, if the next 7 weeks turns into a success..It will trigger everything else to move forward and i would assume at pace..
Imho we do not have to have human data from DX-1 trials to get...
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.51M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.9¢ | $18.68K | 2.075M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 2642383 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 856022 | 2 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
0.9¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.9¢ | 0.9¢ | 0.9¢ | 97616 | ||
| Last updated 11.58am 26/04/2024 ? | |||||
| PAB (ASX) Chart |